This work discusses the development of process systems for 3D printing of pharmaceutical
and biopharmaceutical active ingredients. The development directions, along with
advantages and disadvantages of 2D and 3D printing of such ingredients are presented. The
discussed 3D printing technology enables the transition from mass production of tablets to
individual production, which includes the application of the appropriate combination and
order of active ingredients on an individual tablet, intended for a specific patient, and thus
has a key impact on reducing side effects. Based on the considered mass transfer in process
systems for 3D printing, we defined the possibilities of upgrading the laboratory
experimental film coating of tablets, which include the advantages of 3D printing.
|
